<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM10063</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-10063</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клинический случай</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Case report</subject></subj-group></article-categories><title-group><article-title>Трудности диагностики сахарного диабета типа MODY2 у взрослых</article-title><trans-title-group xml:lang="en"><trans-title>MODY2 diagnostic issues in adults</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4929-1526</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кононенко</surname><given-names>Ирина Владимировна</given-names></name><name name-style="western" xml:lang="en"><surname>Kononenko</surname><given-names>Irina V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник отделения наследственных эндокринопатий Института персонализированной медицины ФГБУ «НМИЦ эндокринологии» Минздрава России</p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">shakhtarina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7324-8344</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глибка</surname><given-names>Анастасия Андреевна</given-names></name><name name-style="western" xml:lang="en"><surname>Glibka</surname><given-names>Anastasiya A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>клинический ординатор</p></bio><bio xml:lang="en"><p>MD, PhD student</p></bio><email xlink:type="simple">anastasiya_glibka@mai.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1346-7545</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубкова</surname><given-names>Наталья Анатольевна</given-names></name><name name-style="western" xml:lang="en"><surname>Zubkova</surname><given-names>Natalya A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший научный сотрудник отделения наследственных эндокринопатий Института персонализированной медицины </p></bio><bio xml:lang="en"><p>PhD</p></bio><email xlink:type="simple">zunata2006@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5825-3287</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Майоров</surname><given-names>Александр Юрьевич</given-names></name><name name-style="western" xml:lang="en"><surname>Mayorov</surname><given-names>Alexander Y.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., заведующий отделом прогнозирования и инноваций диабета Института диабета, профессор кафедры диабетологии и диетологии Института высшего и дополнительного профессионального образования </p></bio><bio xml:lang="en"><p> MD, PhD</p></bio><email xlink:type="simple">education@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8500-4841</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тюльпаков</surname><given-names>Анатолий Николаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Tyulpakov</surname><given-names>Anatoly N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., и.о. директора Института персонализированной медицины </p></bio><bio xml:lang="en"><p>MD, PhD</p></bio><email xlink:type="simple">ant@endocrincentr.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5033-2412</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шмидт</surname><given-names>Ольга Марковна</given-names></name><name name-style="western" xml:lang="en"><surname>Schmidt</surname><given-names>Olga M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-эндокринолог отделения терапии диабета Института диабета </p></bio><bio xml:lang="en"><p>MD</p></bio><email xlink:type="simple">olga_shm@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>25</day><month>10</month><year>2019</year></pub-date><volume>22</volume><issue>4</issue><fpage>384</fpage><lpage>391</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кононенко И.В., Глибка А.А., Зубкова Н.А., Майоров А.Ю., Тюльпаков А.Н., Шмидт О.М., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Кононенко И.В., Глибка А.А., Зубкова Н.А., Майоров А.Ю., Тюльпаков А.Н., Шмидт О.М.</copyright-holder><copyright-holder xml:lang="en">Kononenko I.V., Glibka A.A., Zubkova N.A., Mayorov A.Y., Tyulpakov A.N., Schmidt O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/10063">https://www.dia-endojournals.ru/jour/article/view/10063</self-uri><abstract><p>Традиционно около 90% всех случаев сахарного диабета (СД) у взрослых приходится на долю СД 2 типа, при этом, как правило, СД типа MODY (maturity-onset diabetes of the young – диабет взрослого типа у молодых лиц) остается вовремя не диагностированным, что, в свою очередь, приводит к выбору неправильной тактики лечения. Одной из наиболее распространенных моногенных форм СД является заболевание, обусловленное мутацией гена глюкокиназы (GCK) – СД типа MODY2. Знание особенностей клинической картины заболевания позволяет выделить пациентов с высоким риском наличия мутации гена GCK и направить их для верификации диагноза на молекулярно-генетическое исследование (МГИ).</p><p>В настоящей работе отражены особенности клинической картины СД типа MODY2 и трудности его диагностики у взрослых. Представлен клинический случай пациентки с СД типа MODY2, который в полной мере демонстрирует все особенности данного типа СД.</p></abstract><trans-abstract xml:lang="en"><p>Approximately 90% of all cases of diabetes mellitus in adults involve type 2 diabetes, while the prevalence of maturity-onset diabetes of the young (MODY) remains undetermined leading to inappropriate treatment regimens. One of the most common monogenic forms of diabetes is a disease caused by a mutation in the glucokinase gene, MODY2. Knowledge of the clinical features of the disease allows the selection of patients with a high risk of mutation in the glucokinase gene and verification of diagnosis for molecular genetic research. This paper reflects the clinical features of MODY2 and the difficulties of diagnosis in adults. Furthermore, it presents a clinical case of a patient with MODY2 demonstrating all the features of this type of diabetes. A family member with a mutation in the gene allows to predict the nature of carbohydrate metabolism disorders in first degree relatives. A targeted study of only one part of the glucokinase gene in molecular genetic research is sufficient to confirm the diagnosis in relatives.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>сахарный диабет</kwd><kwd>ген глюкокиназы (GCK)</kwd><kwd>диабет взрослого типа у молодых лиц (MODY)</kwd><kwd>СД типа MODY2</kwd><kwd>гестационный сахарный диабет</kwd><kwd>клинический случай</kwd></kwd-group><kwd-group xml:lang="en"><kwd>diabetes mellitus</kwd><kwd>GCK gene</kwd><kwd>maturity-onset diabetes of the young (MODY)</kwd><kwd>MODY2</kwd><kwd>gestational diabetes</kwd><kwd>case report</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Shields BM, Peters JL, Cooper C, et al. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open. 2015;5(11):e009088. doi: https://doi.org/10.1136/bmjopen-2015-009088</mixed-citation><mixed-citation xml:lang="en">Shields BM, Peters JL, Cooper C, et al. Can clinical features be used to differentiate type 1 from type 2 diabetes? A systematic review of the literature. BMJ Open. 2015;5(11):e009088. doi: https://doi.org/10.1136/bmjopen-2015-009088</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кураева Т.Л., Сечко Е.А., Зильберман Л.И., и др. Молекулярно-генетические и клинические варианты MODY2 и MODY3 у детей в России // Проблемы эндокринологии. — 2015. — Т. 61. — №5. — С. 14-25. [Kuraeva TL, Sechko EA, Zilberman LI, et al. Molecular genetic and clinical variants MODY2 and MODY3 in children in Russia. Problems of Endocrinology. 2016;61(5):14-25. (In Russ.)] doi: https://doi.org/10.14341/probl201561514-25</mixed-citation><mixed-citation xml:lang="en">Кураева Т.Л., Сечко Е.А., Зильберман Л.И., и др. Молекулярно-генетические и клинические варианты MODY2 и MODY3 у детей в России // Проблемы эндокринологии. — 2015. — Т. 61. — №5. — С. 14-25. [Kuraeva TL, Sechko EA, Zilberman LI, et al. Molecular genetic and clinical variants MODY2 and MODY3 in children in Russia. Problems of Endocrinology. 2016;61(5):14-25. (In Russ.)] doi: https://doi.org/10.14341/probl201561514-25</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98(10):4055-4062. doi: https://doi.org/10.1210/jc.2013-1279</mixed-citation><mixed-citation xml:lang="en">Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98(10):4055-4062. doi: https://doi.org/10.1210/jc.2013-1279</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bishay RH, Greenfield JR. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY. Med J Aust. 2016;205(10):480-485. doi: https://doi.org/10.5694/mja16.00458</mixed-citation><mixed-citation xml:lang="en">Bishay RH, Greenfield JR. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY. Med J Aust. 2016;205(10):480-485. doi: https://doi.org/10.5694/mja16.00458</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Amed S, Dean HJ, Panagiotopoulos C, et al. Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children: A prospective national surveillance study. Diabetes Care. 2010;33(4):786-791. doi: https://doi.org/10.2337/dc09-1013</mixed-citation><mixed-citation xml:lang="en">Amed S, Dean HJ, Panagiotopoulos C, et al. Type 2 Diabetes, Medication-Induced Diabetes, and Monogenic Diabetes in Canadian Children: A prospective national surveillance study. Diabetes Care. 2010;33(4):786-791. doi: https://doi.org/10.2337/dc09-1013</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">DellaManna T, Silva MRd, Chacra AR, et al. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation. Arq Bras Endocrinol Metabol. 2012;56(8):490-495. doi: https://doi.org/10.1590/s0004-27302012000800005</mixed-citation><mixed-citation xml:lang="en">DellaManna T, Silva MRd, Chacra AR, et al. Clinical follow-up of two Brazilian subjects with glucokinase-MODY (MODY2) with description of a novel mutation. Arq Bras Endocrinol Metabol. 2012;56(8):490-495. doi: https://doi.org/10.1590/s0004-27302012000800005</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Pruhova S, Dusatkova P, Sumnik Z, et al. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes. 2010;11(8):529-535. doi: https://doi.org/10.1111/j.1399-5448.2010.00646.x</mixed-citation><mixed-citation xml:lang="en">Pruhova S, Dusatkova P, Sumnik Z, et al. Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. Pediatr Diabetes. 2010;11(8):529-535. doi: https://doi.org/10.1111/j.1399-5448.2010.00646.x</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Stern E, Strihan C, Potievsky O, et al. Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4alpha, GCK and TCF1 in patients with MODY in Israel. J Pediatr Endocrinol Metab. 2007;20(8):909-921. doi: https://doi.org/10.1515/jpem.2007.20.8.909</mixed-citation><mixed-citation xml:lang="en">Stern E, Strihan C, Potievsky O, et al. Four novel mutations, including the first gross deletion in TCF1, identified in HNF-4alpha, GCK and TCF1 in patients with MODY in Israel. J Pediatr Endocrinol Metab. 2007;20(8):909-921. doi: https://doi.org/10.1515/jpem.2007.20.8.909</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shields BM, Hicks S, Shepherd MH, et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53(12):2504-2508. doi: https://doi.org/10.1007/s00125-010-1799-4</mixed-citation><mixed-citation xml:lang="en">Shields BM, Hicks S, Shepherd MH, et al. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia. 2010;53(12):2504-2508. doi: https://doi.org/10.1007/s00125-010-1799-4</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Firdous P, Nissar K, Ali S, et al. Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives. Front Endocrinol (Lausanne). 2018;9. doi: https://doi.org/10.3389/fendo.2018.00253</mixed-citation><mixed-citation xml:lang="en">Firdous P, Nissar K, Ali S, et al. Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives. Front Endocrinol (Lausanne). 2018;9. doi: https://doi.org/10.3389/fendo.2018.00253</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Chakera AJ, Steele AM, Gloyn AL, et al. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation. Diabetes Care. 2015;38(7):1383-1392. doi: https://doi.org/10.2337/dc14-2769</mixed-citation><mixed-citation xml:lang="en">Chakera AJ, Steele AM, Gloyn AL, et al. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation. Diabetes Care. 2015;38(7):1383-1392. doi: https://doi.org/10.2337/dc14-2769</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent Neonatal Diabetes Caused by Glucokinase Deficiency: Inborn Error of the Glucose-Insulin Signaling Pathway. Diabetes. 2003;52(11):2854-2860. doi: https://doi.org/10.2337/diabetes.52.11.2854</mixed-citation><mixed-citation xml:lang="en">Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent Neonatal Diabetes Caused by Glucokinase Deficiency: Inborn Error of the Glucose-Insulin Signaling Pathway. Diabetes. 2003;52(11):2854-2860. doi: https://doi.org/10.2337/diabetes.52.11.2854</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Singh R, Pearson ER, Clark PM, Hattersley AT. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations. Diabetologia. 2007;50(3):620-624. doi: https://doi.org/10.1007/s00125-006-0541-8</mixed-citation><mixed-citation xml:lang="en">Singh R, Pearson ER, Clark PM, Hattersley AT. The long-term impact on offspring of exposure to hyperglycaemia in utero due to maternal glucokinase gene mutations. Diabetologia. 2007;50(3):620-624. doi: https://doi.org/10.1007/s00125-006-0541-8</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Зубкова Н.А., Бурумкулова Ф.Ф., Улятовская В.И., и др. Весо-ростовые показатели детей, рожденных от матерей с гестационным сахарным диабетом, обусловленным мутациями в гене глюкокиназы // Сахарный диабет. — 2018 — Т. 21. — №2. — С. 92-98. [Zubkova NA, Burumkulova FF, Ulyatovskaya VI, et al. Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene. Diabetes mellitus. 2018;21(2):92-98. (In Russ.)] doi: https://doi.org/10.14341/DM9429</mixed-citation><mixed-citation xml:lang="en">Зубкова Н.А., Бурумкулова Ф.Ф., Улятовская В.И., и др. Весо-ростовые показатели детей, рожденных от матерей с гестационным сахарным диабетом, обусловленным мутациями в гене глюкокиназы // Сахарный диабет. — 2018 — Т. 21. — №2. — С. 92-98. [Zubkova NA, Burumkulova FF, Ulyatovskaya VI, et al. Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene. Diabetes mellitus. 2018;21(2):92-98. (In Russ.)] doi: https://doi.org/10.14341/DM9429</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Меликян М.А., Карева М.А. Врожденный гиперинсулинизм: Пособие для врачей. — М.; 2017. [Melikyan MА, Kareva MА. Vrozhdennyy giperinsulinizm: Manual for doctors. Moscow; 2017. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Меликян М.А., Карева М.А. Врожденный гиперинсулинизм: Пособие для врачей. — М.; 2017. [Melikyan MА, Kareva MА. Vrozhdennyy giperinsulinizm: Manual for doctors. Moscow; 2017. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015;28(3-4). doi: https://doi.org/10.1515/jpem-2014-0384</mixed-citation><mixed-citation xml:lang="en">Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015;28(3-4). doi: https://doi.org/10.1515/jpem-2014-0384</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ellard S, Beards F, Allen LIS, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 2000;43(2):250-253. doi: https://doi.org/10.1007/s001250050038</mixed-citation><mixed-citation xml:lang="en">Ellard S, Beards F, Allen LIS, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria. Diabetologia. 2000;43(2):250-253. doi: https://doi.org/10.1007/s001250050038</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Lachance C-H. Practical Aspects of Monogenic Diabetes: A Clinical Point of View. Can J Diabetes. 2016;40(5):368-375. doi: https://doi.org/10.1016/j.jcjd.2015.11.004</mixed-citation><mixed-citation xml:lang="en">Lachance C-H. Practical Aspects of Monogenic Diabetes: A Clinical Point of View. Can J Diabetes. 2016;40(5):368-375. doi: https://doi.org/10.1016/j.jcjd.2015.11.004</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Кураева Т.Л., Зильберман Л.И., Титович Е.В., и др. Генетика моногенных форм сахарного диабета // Сахарный диабет. — 2011 — Т. 14. — №1. — С. 20-27. [Kuraeva TL, Zil’berman LI, Titovich EV, et al. Genetics of monegenic forms of diabetes mellitus. Diabetes mellitus. 2011;14(1):20-27. (In Russ.)] doi: https://doi.org/10.14341/2072-0351-6246.</mixed-citation><mixed-citation xml:lang="en">Кураева Т.Л., Зильберман Л.И., Титович Е.В., и др. Генетика моногенных форм сахарного диабета // Сахарный диабет. — 2011 — Т. 14. — №1. — С. 20-27. [Kuraeva TL, Zil’berman LI, Titovich EV, et al. Genetics of monegenic forms of diabetes mellitus. Diabetes mellitus. 2011;14(1):20-27. (In Russ.)] doi: https://doi.org/10.14341/2072-0351-6246.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature. 1992;356(6365):162-164. doi: https://doi.org/10.1038/356162a0</mixed-citation><mixed-citation xml:lang="en">Froguel P, Vaxillaire M, Sun F, et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature. 1992;356(6365):162-164. doi: https://doi.org/10.1038/356162a0</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Солвей Дж.Г. Наглядная медицинская биохимия: учебное пособие. / Под ред. Северина Е.С. — М.: ГЭОТАР-Медиа; 2015. [Solvay JG. Severin ES, editor. Naglyadnaya meditsinskaya biokhimiya: tutorial. Moscow: GEOTАR-Media; 2015. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Солвей Дж.Г. Наглядная медицинская биохимия: учебное пособие. / Под ред. Северина Е.С. — М.: ГЭОТАР-Медиа; 2015. [Solvay JG. Severin ES, editor. Naglyadnaya meditsinskaya biokhimiya: tutorial. Moscow: GEOTАR-Media; 2015. (In Russ.)]</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Lu B, Munoz-Gomez M, Ikeda Y. The two major glucokinase isoforms show conserved functionality in β-cells despite different subcellular distribution. Biol Chem. 2018;399(6):565-576. doi: https://doi.org/10.1515/hsz-2018-0109</mixed-citation><mixed-citation xml:lang="en">Lu B, Munoz-Gomez M, Ikeda Y. The two major glucokinase isoforms show conserved functionality in β-cells despite different subcellular distribution. Biol Chem. 2018;399(6):565-576. doi: https://doi.org/10.1515/hsz-2018-0109</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">hgmd.cf.ac.uk [Internet]. The Human Gene Mutation Database [cited 2019 Jan 23]. Available from: http://www.hgmd.cf.ac.uk/ac/index.php.</mixed-citation><mixed-citation xml:lang="en">hgmd.cf.ac.uk [Internet]. The Human Gene Mutation Database [cited 2019 Jan 23]. Available from: http://www.hgmd.cf.ac.uk/ac/index.php.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Osbak KK, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat. 2009;30(11):1512-1526. doi: https://doi.org/10.1002/humu.21110</mixed-citation><mixed-citation xml:lang="en">Osbak KK, Colclough K, Saint-Martin C, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat. 2009;30(11):1512-1526. doi: https://doi.org/10.1002/humu.21110</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Froguel P, Zouali H, Vionnet N, et al. Familial Hyperglycemia Due to Mutations in Glucokinase -- Definition of a Subtype of Diabetes Mellitus. New Eng J Med. 1993;328(10):697-702. doi: https://doi.org/10.1056/nejm199303113281005</mixed-citation><mixed-citation xml:lang="en">Froguel P, Zouali H, Vionnet N, et al. Familial Hyperglycemia Due to Mutations in Glucokinase -- Definition of a Subtype of Diabetes Mellitus. New Eng J Med. 1993;328(10):697-702. doi: https://doi.org/10.1056/nejm199303113281005</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Velho G, Hattersley AT, Froguel P. Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia. 2000;43(8):1060-1063. doi: https://doi.org/10.1007/s001250051490</mixed-citation><mixed-citation xml:lang="en">Velho G, Hattersley AT, Froguel P. Maternal diabetes alters birth weight in glucokinase-deficient (MODY2) kindred but has no influence on adult weight, height, insulin secretion or insulin sensitivity. Diabetologia. 2000;43(8):1060-1063. doi: https://doi.org/10.1007/s001250051490</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy. Best Pract Res Clin Endocrinol Metab. 2010;24(4):605-615. doi: https://doi.org/10.1016/j.beem.2010.05.008</mixed-citation><mixed-citation xml:lang="en">Colom C, Corcoy R. Maturity onset diabetes of the young and pregnancy. Best Pract Res Clin Endocrinol Metab. 2010;24(4):605-615. doi: https://doi.org/10.1016/j.beem.2010.05.008</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Dickens LT, Naylor RN. Clinical Management of Women with Monogenic Diabetes During Pregnancy. Curr Diab Rep. 2018;18(3). doi: https://doi.org/10.1007/s11892-018-0982-8</mixed-citation><mixed-citation xml:lang="en">Dickens LT, Naylor RN. Clinical Management of Women with Monogenic Diabetes During Pregnancy. Curr Diab Rep. 2018;18(3). doi: https://doi.org/10.1007/s11892-018-0982-8</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Njølstad PR, Molven A. To test, or not to test: time for a MODY calculator? Diabetologia. 2012;55(5):1231-1234. doi: https://doi.org/10.1007/s00125-012-2514-4</mixed-citation><mixed-citation xml:lang="en">Njølstad PR, Molven A. To test, or not to test: time for a MODY calculator? Diabetologia. 2012;55(5):1231-1234. doi: https://doi.org/10.1007/s00125-012-2514-4</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">diabetesgenes.org [Internet]. MODY Probability Calculator [cited 2019 Jan 23]. Available from: https://www.diabetesgenes.org/mody-probability-calculator .</mixed-citation><mixed-citation xml:lang="en">diabetesgenes.org [Internet]. MODY Probability Calculator [cited 2019 Jan 23]. Available from: https://www.diabetesgenes.org/mody-probability-calculator .</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
